Response Adapted Therapy With Bortezomib/Dexamethasone Followed by Addition of Lenalidomide in Non Responders as Initial Treatment for Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Related studies linked through entity extraction aliases.